About Dilon Technologies
Dilon Technologies is a medical device manufacturer that focuses on products that assist in the fight against breast cancer. The company offers a portfolio of medical devices that includes the Navigator System, a trusted brand and world-renowned surgical gamma probe for radio-guided lymphatic mapping and tumor localization, the MarginProbe, a groundbreaking technology for accurate microscopic margin assessment in breast cancer surgery, and the TrueView 100 Pro, a Specimen Radiography System (SRS) that uses advanced radiography and automated software to precisely identify tumor lesions in resected or biopsied breast tissue. The company was founded in 1999 and is based in Newport News, Virginia.
Missing: Dilon Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Dilon Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Dilon Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Dilon Technologies is included in 5 Expert Collections, including Women's Health & Wellness.
Women's Health & Wellness
Startups focused on providing products and services catering to women's health and wellbeing.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Dilon Technologies Patents
Dilon Technologies has filed 6 patents.
Medical imaging, Graphical user interfaces, Medical equipment, Medical physics, Electromagnetic radiation
Medical imaging, Graphical user interfaces, Medical equipment, Medical physics, Electromagnetic radiation
Latest Dilon Technologies News
Dec 9, 2022
| Dilon Technologies, Ziteo News Provided By Share This Article Gamma Probe Device Gamma probe device enables surgeons to identify radio-labelled tissue during pre-operation and intra-operation for radio guided diagnosis and surgery. BURLINGAME, CALIFORNIA, UNITED STATES, December 9, 2022 / EINPresswire.com / -- Using a gamma probe instrument, surgeons can detect radio-labeled tissue both before and during surgery in order to do radio guided diagnostics and surgery. Locating tissues including tumours, parathyroid glands, and lymph nodes throughout the human body can be challenging for surgeons. As a result, the surgeon can make a smaller incision thanks to the proper use of a gamma probe, and the tissues of interest have been found. Gamma probes are frequently used in the surgical process known as Sentinel Node Biopsy, which is intended to ascertain whether a tumour has metastasized, or migrated to new sites.Breast cancer and melanoma biopsies are frequently used for staging, and they are also more prevalent for staging other cancers. For gamma probe devices, a carrier substance or radionuclide such as technetium-99m, nanocolloid, or sestamibi is utilised as a tracer. The radioisotope Technetium-99m is most frequently used in Sentinel Node Biopsies. There are three types of gamma probe devices: handheld, table-top, and trolley mounted. The market for closed probe devices is fueled by reasons such as the introduction of products with cutting-edge features, an increase in the number of breast cancer cases, and public awareness of the advantages of gamma radiation over other detection methods like X-rays. Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1590 Edition: 2022 Objectives of the Report: ➢ To estimate the market shares of major segments of the Industry ➢ To highlight the development of the Gamma Probe Device Market in different parts of the world. ➢ To analyze and study micro-markets in terms of their contributions, prospects, and individual growth trends. ➢ To offer precise and useful details about factors affecting revenue growth over the forecast period. ➢ To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Gamma Probe Device market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches. List of Key players in the global Gamma Probe Device Market: Dilon Technologies, Inc., Lake Shore Cryotronics, Inc., Wake Medical Ltd., Ziteo Inc., Intramedical Imaging, LLC and Berkeley Nucleonics Corporation. SWOT Analysis of Global Gamma Probe Device Market: In addition to market share analysis of companies, in-depth profile, product/service, and business overview, the study focuses on revenue analysis, as well as SWOT analysis, to better correlate market competitiveness. Information source and Research Methodology: Our researchers compiled the study utilizing primary (surveys and interviews) and secondary (industry body databases, reliable paid sources, and trade magazines) data collection methods. The report contains a thorough qualitative and quantitative analysis. Growth trends, micro-and macroeconomic indicators, as well as legislation and government policies are all covered in the research. To Purchase Report, Click Here - https://www.coherentmarketinsights.com/insight/buy-now/1590 Detailed Segmentation: Purchasing the Gamma Probe Device Market for the Following Reasons: ⮞The study examines emerging market trends as well as the likelihood that various trends will impact expansion. ⮞The analysis also discusses the factors, challenges, and opportunities that will have a significant impact on the global Gamma Probe Device industry. ⮞Technological tools and benchmarks that reflect the industry's projected growth of the Gamma Probe Device industry. ⮞The research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates. ⮞The research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates. What are the goals of the report? ⮞The predicted market size for the Gamma Probe Device Market Industry at the conclusion of the forecast period is shown in this market report. ⮞The paper also analyses market sizes in the past and present. ⮞The charts show the year-over-year growth (percent) and compound annual growth rate (CAGR) for the given projected period based on a variety of metrics. ⮞The research contains a market overview, geographical breadth, segmentation, and financial performance of main competitors. ⮞The research evaluates the current situation of the industry in North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa,as well as future growth opportunities. ⮞The study examines the future period’s growth rate, market size, and market worth. Some of the Key Questions Answered in this Report: ⁃ What will be the market size and the growth rate by the end of the forecast period? ⁃ What are the key Gamma Probe Device Market trends impacting the growth of the market? ⁃ What are the potential growth opportunities and threats faced by the leading competitors in the market ⁃ What are the key outcomes of Porter’s five forces analysis and the SWOT analysis of the key players functioning in the global Gamma Probe Device Market? ⁃ This report gives all the information regarding industry Overview, analysis and revenue of this market. ⁃ What are the market opportunities and threats faced by the vendors in the global Gamma Probe Device Market? Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1590 Table of Content 1.5 Market Size Analysis from 2022 to 2028 11.6 COVID-19 Outbreak: Gamma Probe Device Industry Impact Chapter 2 Gamma Probe Device Competition by Types, Applications, and Top Regions and Countries 2.1 Market (Volume and Value) by Type 2.3 Market (Volume and Value) by Regions Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.2 Regional Production Market Analysis Chapter 4 Gamma Probe Device Sales, Consumption, Export, Import by Regions (2016-2021) Chapter 5 North America Industry Market Analysis Chapter 6 East Asia Gamma Probe Device Market Analysis Chapter 7 Europe Industry Market Analysis Chapter 8 South Asia Gamma Probe Device Market Analysis Chapter 9 Southeast Asia Market Analysis Chapter 10 Middle East Gamma Probe Device Market Analysis Chapter 11 Africa Market Analysis Chapter 12 Oceania Market Analysis Chapter 13 South America Gamma Probe Device Market Analysis Chapter 14 Company Profiles and Key Figures in Gamma Probe Device Business Chapter 15 Gamma Probe Device Market Forecast (2022-2028) Chapter 16 Conclusions Continued.... Finally, the report majorly enlightens the key growth and limiting factors which majorly targets at the center of the market affecting the growth and its development in either positive or negative extent. The report also specifies the impact of regulations and policies implemented by the administration over the current growth and upcoming opportunities that may lead to the market development escalation. The Gamma Probe Device Market report offers a superior vision of the global market, which will help clients to manage the business precisely with better growth and expansion compared to its contenders in the market. About Coherent Market Insights: Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. Mr. Shah +1 206-701-6702
Dilon Technologies Frequently Asked Questions (FAQ)
When was Dilon Technologies founded?
Dilon Technologies was founded in 1999.
Where is Dilon Technologies's headquarters?
Dilon Technologies's headquarters is located at 12050 Jefferson Ave, Newport News.
What is Dilon Technologies's latest funding round?
Dilon Technologies's latest funding round is Unattributed - III.
How much did Dilon Technologies raise?
Dilon Technologies raised a total of $21.06M.
Who are the investors of Dilon Technologies?
Investors of Dilon Technologies include Paycheck Protection Program.
Who are Dilon Technologies's competitors?
Competitors of Dilon Technologies include Gabbi, COTA, Tempus, Cellens, Careology, Skinive, Hyivy Health, Translational Genomics Research Institute, C.D Intelligence, Optellum and 51 more.
Compare Dilon Technologies to Competitors
Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine-learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions. It serves clients in the healthcare sector. The company was founded in 2015 and is based in Chicago, Illinois.
Biofourmis discovers, develops, and delivers clinically-validated, software-based therapeutics. Biofourmis has built Biovitals, a personalized, AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of its digital therapeutics product pipeline across multiple therapeutic areas, including heart failure, oncology, acute coronary syndrome, COPD, and chronic pain. It serves clients operating in the healthcare sector. The company was founded in 2015 and is based in Boston, Massachusetts.
Thynk Health optimizes data-driven workflows and provides operational and clinical analytics for lung cancer screening programs and other quality initiatives. The company was founded in 2014 and is based in Lexington, Kentucky.
Translational Genomics Research Institute (TGen) is a non-profit organization dedicated to conducting research focused on helping patients with cancer, neurological disorders, and diabetes through translational research. The organization was founded in 2002 and is based in Phoenix, Arizona.
C.D Intelligence focuses on the fields of life science and big health, and is committed to combining traditional medical care with artificial intelligence and big data to provide patients with full rehabilitation management, thereby improving the quality of life of cancer patients and prolonging the life cycle of patients. The company was founded in 2017 and is based in Shanghai, China.
Careology provides user-centered connected solutions that link patients with a cancer diagnosis to those responsible for their care. It offers healthcare professionals health information and remote monitoring insights to help them in their medical procedures. The company was founded in 2017 and is based in London, U.K.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.